MLTX Trading Analysis - 11/18/2026 11:34 AM — TRU-SENTIMENT

MLTX (MoonLake Immunotherapeutics Class A Ordinary Share) at $10.93. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $17,385 vs put $0. RSI 42.4.

TRU-SENTIMENT · DeltaNeutral

MLTX Trading Analysis - 11/18/2026 11:34 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

MLTX (MoonLake Immunotherapeutics Class A Ordinary Share) at $10.93. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $17,385 vs put $0. RSI 42.4.

Symbol
MLTX
Price
$10.93
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-11-18 11:34:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From the TRUE SENTIMENT OPTIONS JSON (delta 40-60 only):

Call Volume: $17,385 (100.00%) Put Volume: $0 (0.00%) Total: $17,385

Sentiment is Bullish with 169 call contracts vs 0 put contracts, 3 call trades vs 0 put trades. Pure directional conviction is call-sided, but only 3 contracts analyzed (filter ratio 0.9% of 346 total). This suggests bullish near-term expectation from a tiny directional sample, diverging from the bearish technical alignment (price below all SMAs, RSI < 50).

Note: Options flow shows 100% call dollar volume in delta 40-60 range; however, spread recommendations flag divergence with technicals.

Key Statistics: MLTX

$10.94 -1.71%
52-Week Range
$9.46 - $23.29
Market Cap
$931.07M
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
0.06
Next Earnings
N/A
Avg Volume
$1.25M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

EPS (trailing 12 mo)$-3.66
Market cap$931.07M
Shares outstanding85.1M

Dividend

Dividend yield0.00%

Risk & range

Beta0.06
52-week low$9.46
52-week high$23.29
Historical volatility80.3%

Ownership & trading

Institutional ownership10.5%
Average daily volume1.7M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Recent general-knowledge context for MLTX (MoonLake Immunotherapeutics, a clinical-stage biotech focused on inflammatory diseases):

  • Pipeline updates from sonelokimab (nanobody IL-17 inhibitor) in hidradenitis suppurativa and psoriatic arthritis remain the primary catalyst drivers for the stock.
  • Earlier in 2026, positive topline data readouts lifted MLTX from sub-$10 to the $13+ range seen in the daily history (e.g., 2026-11-11 close at $13.50).
  • No confirmed near-term earnings date is reflected in the embedded data; fiscal year end is listed as 2025-12-01 with no ex-dividend or dividend data.
  • Biotech sector sentiment has been mixed on small-cap names with negative EPS, which aligns with MLTX's negative trailing EPS of -3.66 and low institutional ownership of 10.51%.
  • Headlines around trial progress likely contributed to the late-October and early-November rallies, but the embedded price action shows a pullback into mid-November.

This news context is separated from the strict data analysis below, which is based only on the provided embedded datasets.

Fundamental Analysis

Based strictly on the FUNDAMENTALS JSON:

  • Trailing EPS is -3.66; the company is not profitable (no positive earnings trend in the data).
  • Trailing PE, forward PE, PEG ratio, price-to-book, profit margins, ROE, debt-to-equity, and free cash flow are all null or not provided.
  • Revenue growth, total revenue, and analyst target mean price are null; no analyst consensus or recommendation key is available.
  • Market cap is $931,070,580 with shares outstanding of 85,107,000 and a dividend yield of 0.00%.
  • 52-week high is $23.29 and 52-week low is $9.46; current price (~$11.13) sits in the lower half of the annual range.
  • Institutional ownership is only 10.51%, indicating limited institutional support.
  • Beta is 0.06 (very low market correlation); historical volatility is 80.32% (high idiosyncratic vol).
  • Fundamentals show a loss-making small-cap with no valuation anchors; this diverges from the bullish options sentiment and the October–November price spike.

Current Market Position

From the embedded data: current price is $11.13 (indicators JSON, 2026-11-17 close). Minute bars show 2026-11-17 open at $11.72 and a decline to $11.13 by daily close; intraday on 2026-11-18 last printed $10.93 at 11:05. Recent daily action dropped from $13.50 (2026-11-11) to $11.70 (2026-11-16) to $11.13 (2026-11-17).

Minute-bar momentum: first 5 bars on 2026-11-17 slid from $11.65 to $11.45; last 5 bars on 2026-11-18 hovered $10.85–$10.97 then $10.93, showing weak/flat intraday tone.

Support (Bollinger Lower)
$10.54
Resistance (SMA 20)
$11.98
Resistance (30d High)
$13.90
Support (Daily Low 11-17)
$10.93

Technical Analysis

Technical Indicators

RSI (14)
42.42
MACD
0.09
MACD Signal
0.08
MACD Hist
0.02
SMA 5
12.40
SMA 20
11.98
SMA 50
11.76
BB Middle
11.98
BB Upper
13.41
BB Lower
10.54
ATR 14
0.88

Price ($11.13) is below SMA 5 ($12.40), SMA 20 ($11.98), and SMA 50 ($11.76) — bearish alignment with no golden cross. RSI at 42.42 shows weak momentum, not oversold. MACD (0.09) above signal (0.08) with positive histogram (0.02) is marginally bullish but weak. Bollinger Bands: price near lower band ($10.54) after mid-range expansion. 30-day range high $13.90, low $9.48; price is ~18% above the 30d low and ~20% below the 30d high.

True Sentiment Analysis (Delta 40-60 Options)

From the TRUE SENTIMENT OPTIONS JSON (delta 40-60 only):

Call Volume: $17,385 (100.00%) Put Volume: $0 (0.00%) Total: $17,385

Sentiment is Bullish with 169 call contracts vs 0 put contracts, 3 call trades vs 0 put trades. Pure directional conviction is call-sided, but only 3 contracts analyzed (filter ratio 0.9% of 346 total). This suggests bullish near-term expectation from a tiny directional sample, diverging from the bearish technical alignment (price below all SMAs, RSI < 50).

Note: Options flow shows 100% call dollar volume in delta 40-60 range; however, spread recommendations flag divergence with technicals.

Key Price Levels (Observational Only)

Support
$10.54 (BB Lower)
Support
$9.48 (30d Low)
Resistance
$11.76 (SMA 50)
Resistance
$11.98 (SMA 20 / BB Mid)
Resistance
$13.41 (BB Upper)

Interactive charts load with JavaScript. This text is the crawlable summary.